Loss of FAS/FASL signalling does not reduce apoptosis in Sharpin null mice

Exp Dermatol. 2017 Sep;26(9):820-822. doi: 10.1111/exd.13289. Epub 2017 May 3.

Abstract

Mice with mutations in SHANK-associated RH domain interactor (Sharpin) develop a hypereosinophilic auto-inflammatory disease known as chronic proliferative dermatitis. Affected mice have increased apoptosis in the keratinocytes of the skin, oesophagus and forestomach driven by extrinsic TNF receptor-mediated apoptotic signalling pathways. FAS receptor signalling is an extrinsic apoptotic signalling mechanism frequently involved in inflammatory skin diseases. Compound mutations in Sharpin and Fas or Fasl were created to determine whether these death domain proteins influenced the cutaneous phenotype in Sharpin null mice. Both Sharpin/Fas and Sharpin/Fasl compound mutant mice developed an auto-inflammatory phenotype similar to that seen in Sharpin null mice, indicating that initiation of apoptosis by FAS signalling is likely not involved in the pathogenesis of this disease.

Keywords: Fas; Fasl; SHARPIN; cpdm; apoptosis.

Publication types

  • Letter

MeSH terms

  • Animals
  • Apoptosis
  • Carrier Proteins / physiology*
  • Fas Ligand Protein / genetics
  • Fas Ligand Protein / metabolism*
  • Intracellular Signaling Peptides and Proteins
  • Keratinocytes / physiology*
  • Mice
  • Skin Diseases / etiology*
  • Tumor Necrosis Factor-alpha / metabolism
  • fas Receptor / genetics
  • fas Receptor / metabolism*

Substances

  • Carrier Proteins
  • Fas Ligand Protein
  • Intracellular Signaling Peptides and Proteins
  • Sipl1 protein, mouse
  • Tumor Necrosis Factor-alpha
  • fas Receptor